Befunolol: Difference between revisions
m Protected "Befunolol": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
Kiran Singh (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{Drugbox | {{Drugbox | ||
| IUPAC_name = 1-[7-[2-hydroxy-3-(propan-2-ylamino)propoxy]-<br>1-benzofuran-2-yl]ethanone | | IUPAC_name = 1-[7-[2-hydroxy-3-(propan-2-ylamino)propoxy]-<br>1-benzofuran-2-yl]ethanone | ||
| image = Befunolol. | | image = Befunolol.png | ||
| CAS_number = 39552-01-7 | | CAS_number = 39552-01-7 | ||
| ATC_prefix = S01 | | ATC_prefix = S01 | ||
Line 24: | Line 24: | ||
| routes_of_administration = | | routes_of_administration = | ||
}} | }} | ||
__Notoc__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Befunolol''' ([[International Nonproprietary Name|INN]]) is a [[beta blocker]] with [[beta blocker#Intrinsic sympathomimetic activity|intrinsic sympathomimetic activity]] used in the management of [[glaucoma|open-angle glaucoma]]. | '''Befunolol''' ([[International Nonproprietary Name|INN]]) is a [[beta blocker]] with [[beta blocker#Intrinsic sympathomimetic activity|intrinsic sympathomimetic activity]] used in the management of [[glaucoma|open-angle glaucoma]]. | ||
{{Antiglaucoma preparations and miotics}} | {{Antiglaucoma preparations and miotics}} | ||
[[Category:Beta blockers]] | [[Category:Beta blockers]] | ||
[[Category:Drug]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Latest revision as of 14:43, 13 April 2015
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C16H21NO4 |
Molar mass | 291.342 g/mol |
WikiDoc Resources for Befunolol |
Articles |
---|
Most recent articles on Befunolol |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Befunolol at Clinical Trials.gov Clinical Trials on Befunolol at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Befunolol
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Befunolol Discussion groups on Befunolol Directions to Hospitals Treating Befunolol Risk calculators and risk factors for Befunolol
|
Healthcare Provider Resources |
Causes & Risk Factors for Befunolol |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Befunolol (INN) is a beta blocker with intrinsic sympathomimetic activity used in the management of open-angle glaucoma.
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Beta blockers
- Drug